BR112012001899B8 - soluções compreendendo polietileno glicol e eletrólitos, seu método de preparação, e recipiente e kit que as compreendem - Google Patents
soluções compreendendo polietileno glicol e eletrólitos, seu método de preparação, e recipiente e kit que as compreendemInfo
- Publication number
- BR112012001899B8 BR112012001899B8 BR112012001899A BR112012001899A BR112012001899B8 BR 112012001899 B8 BR112012001899 B8 BR 112012001899B8 BR 112012001899 A BR112012001899 A BR 112012001899A BR 112012001899 A BR112012001899 A BR 112012001899A BR 112012001899 B8 BR112012001899 B8 BR 112012001899B8
- Authority
- BR
- Brazil
- Prior art keywords
- solutions
- polyethylene glycol
- solution
- electrolytes
- kit
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 3
- 239000003792 electrolyte Substances 0.000 title abstract 2
- 239000000243 solution Substances 0.000 abstract 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 206010056325 Faecaloma Diseases 0.000 abstract 1
- 208000008415 Fecal Impaction Diseases 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0913295.2A GB0913295D0 (en) | 2009-07-30 | 2009-07-30 | Improvements in and relating to pharmaceutical compositions |
GB0913295.2 | 2009-07-30 | ||
PCT/GB2010/001455 WO2011012866A1 (en) | 2009-07-30 | 2010-07-30 | Solutions comprising polyethylene glycol and electrolytes |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012001899A2 BR112012001899A2 (pt) | 2016-03-15 |
BR112012001899B1 BR112012001899B1 (pt) | 2021-05-04 |
BR112012001899B8 true BR112012001899B8 (pt) | 2021-05-25 |
Family
ID=41067102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012001899A BR112012001899B8 (pt) | 2009-07-30 | 2010-07-30 | soluções compreendendo polietileno glicol e eletrólitos, seu método de preparação, e recipiente e kit que as compreendem |
Country Status (32)
Country | Link |
---|---|
US (2) | US20120135090A1 (pt) |
EP (1) | EP2459218B1 (pt) |
JP (1) | JP5708943B2 (pt) |
KR (1) | KR101868834B1 (pt) |
CN (2) | CN102548580A (pt) |
AR (2) | AR077347A1 (pt) |
AT (1) | AT12341U1 (pt) |
AU (1) | AU2010277354B2 (pt) |
BE (1) | BE1019753A5 (pt) |
BR (1) | BR112012001899B8 (pt) |
CA (1) | CA2769247C (pt) |
CY (1) | CY1122081T1 (pt) |
DK (1) | DK2459218T3 (pt) |
EA (1) | EA025112B1 (pt) |
ES (1) | ES2388095B1 (pt) |
FR (1) | FR2948569B3 (pt) |
GB (3) | GB0913295D0 (pt) |
HK (1) | HK1150430A1 (pt) |
HR (1) | HRP20191465T1 (pt) |
HU (1) | HUE046705T2 (pt) |
IT (1) | IT1402374B1 (pt) |
LT (1) | LT2459218T (pt) |
MX (1) | MX337114B (pt) |
NL (1) | NL2005176C2 (pt) |
NZ (1) | NZ597822A (pt) |
PL (1) | PL2459218T3 (pt) |
PT (1) | PT2459218T (pt) |
RS (1) | RS59294B1 (pt) |
SI (1) | SI2459218T1 (pt) |
TW (1) | TWI478716B (pt) |
WO (1) | WO2011012866A1 (pt) |
ZA (1) | ZA201200661B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2862566T (pt) | 2011-01-31 | 2022-06-02 | Norgine Healthcare B V | Melhorias em, e relativas a, composições |
GB201200637D0 (en) | 2012-01-13 | 2012-02-29 | Norgine Bv | Improvements in and relating to compositions |
TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
CN102600201B (zh) * | 2012-02-07 | 2014-07-16 | 舒泰神(北京)生物制药股份有限公司 | 用于通便和清肠的药物组合物及其制备方法 |
US20140065076A1 (en) * | 2012-08-30 | 2014-03-06 | Otsuka Pharmaceutical Co. Ltd. | Container with concentrated substance and method of using the same |
IN2015DN01704A (pt) | 2012-09-11 | 2015-05-22 | Norgine Bv | |
EA034234B1 (ru) | 2013-03-15 | 2020-01-20 | Брейнтри Лабораторис, Инк. | Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения |
CN112494511A (zh) * | 2020-12-06 | 2021-03-16 | 天津康哲医药科技发展有限公司 | 一种聚乙二醇钠钾口服药物制剂的制备 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0231356A1 (en) * | 1985-08-01 | 1987-08-12 | Braintree Laboratories, Inc. | Low-sodium laxative and lavage formulation |
JP2596764B2 (ja) | 1987-11-18 | 1997-04-02 | ルセル森下株式会社 | 腸管洗浄液剤 |
US5378470A (en) | 1989-07-25 | 1995-01-03 | Henning Berlin Gmbh | Rectally administered pharmaceutical preparation |
JPH08505609A (ja) | 1992-11-24 | 1996-06-18 | ブロック・ドラッグ・カンパニー・インク | 胃腸洗浄用薬剤組成物 |
RU2111741C1 (ru) * | 1994-10-27 | 1998-05-27 | Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности Российской Федерации | Вещество для общего промывания желудочно-кишечного тракта |
US5710183A (en) | 1995-07-14 | 1998-01-20 | Halow; George M. | Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
US6071523A (en) | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
US6048901A (en) | 1999-04-20 | 2000-04-11 | Braintree Laboratories, Inc. | Method of reducing intestinal gas, cramping and anorectal irritation |
IL137275A0 (en) | 2000-07-12 | 2001-07-24 | Yosefus Azaria | Pharmaceutical composition for the treatment of anal fissures |
US20050003021A1 (en) | 2001-10-29 | 2005-01-06 | Takayuki Sugiyama | Bowel cleansing agent |
US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
US7291324B2 (en) * | 2002-10-22 | 2007-11-06 | Braintree Laboratories Inc. | Method of bowel cleansing |
GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
US7332184B2 (en) | 2003-03-28 | 2008-02-19 | Queen's University At Kingston | Colonic cleansing composition and method |
ES2319655T3 (es) | 2003-07-09 | 2009-05-11 | Braintree Laboratories, Inc. | Uso de laxantes para tratar el sindrome del intestino irritable. |
JP2007511610A (ja) * | 2003-11-17 | 2007-05-10 | ブレーントリー ラボラトリーズ インコーポレーティッド | 治療用peg溶液濃縮物 |
GB0409104D0 (en) * | 2004-04-23 | 2004-05-26 | Norgine Europe Bv | Compressed pharmaceutical compositions |
EP1877039A4 (en) * | 2005-05-06 | 2010-08-18 | Salix Pharmaceuticals Inc | Polyethylene glycol GUT CLEANING COMPOSITION |
US20070082061A1 (en) * | 2005-10-07 | 2007-04-12 | Nelson Ayala | Reduction of saltiness with sweeteners |
DE102006001199A1 (de) | 2006-01-10 | 2007-07-12 | Medicoforum Gmbh | Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans |
ES2278537B1 (es) | 2006-01-30 | 2008-09-16 | Laboratorios Casen-Fleet, S.L. | Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso. |
CN1850112B (zh) * | 2006-03-06 | 2011-06-29 | 北京圣永制药有限公司 | 聚乙二醇-电解质口服溶液 |
DE112008002398A5 (de) * | 2007-09-22 | 2010-07-29 | Bayer Consumer Care Ag | Zusammensetzung mit Wirkstoffkombination aus einem Laxans und einem Entschäumer zur Behandlung von Obstipation |
US8362083B2 (en) * | 2008-01-15 | 2013-01-29 | C.B. Fleet Company Inc. | Taste-masked docusate compositions |
-
2009
- 2009-07-30 GB GBGB0913295.2A patent/GB0913295D0/en not_active Ceased
-
2010
- 2010-07-30 AT AT0075910U patent/AT12341U1/de not_active IP Right Cessation
- 2010-07-30 IT ITMI2010A001436A patent/IT1402374B1/it active
- 2010-07-30 CN CN2010800327206A patent/CN102548580A/zh active Pending
- 2010-07-30 WO PCT/GB2010/001455 patent/WO2011012866A1/en active Application Filing
- 2010-07-30 AU AU2010277354A patent/AU2010277354B2/en active Active
- 2010-07-30 AR ARP100102787A patent/AR077347A1/es not_active Application Discontinuation
- 2010-07-30 FR FR1056333A patent/FR2948569B3/fr not_active Expired - Lifetime
- 2010-07-30 SI SI201031928T patent/SI2459218T1/sl unknown
- 2010-07-30 BR BR112012001899A patent/BR112012001899B8/pt active IP Right Grant
- 2010-07-30 EA EA201200220A patent/EA025112B1/ru unknown
- 2010-07-30 CA CA2769247A patent/CA2769247C/en active Active
- 2010-07-30 ES ES201090080A patent/ES2388095B1/es active Active
- 2010-07-30 KR KR1020127005284A patent/KR101868834B1/ko active IP Right Grant
- 2010-07-30 GB GB201012903A patent/GB2472324C/en active Active
- 2010-07-30 BE BE2010/0471A patent/BE1019753A5/fr active
- 2010-07-30 PL PL10739973T patent/PL2459218T3/pl unknown
- 2010-07-30 LT LTEP10739973.5T patent/LT2459218T/lt unknown
- 2010-07-30 GB GB1108383.9A patent/GB2478076B/en active Active
- 2010-07-30 DK DK10739973.5T patent/DK2459218T3/da active
- 2010-07-30 NL NL2005176A patent/NL2005176C2/en active
- 2010-07-30 US US13/387,791 patent/US20120135090A1/en not_active Abandoned
- 2010-07-30 RS RSP20191169 patent/RS59294B1/sr unknown
- 2010-07-30 CN CN201410088148.5A patent/CN103932979B/zh active Active
- 2010-07-30 MX MX2012001108A patent/MX337114B/es active IP Right Grant
- 2010-07-30 NZ NZ597822A patent/NZ597822A/xx unknown
- 2010-07-30 HU HUE10739973A patent/HUE046705T2/hu unknown
- 2010-07-30 PT PT10739973T patent/PT2459218T/pt unknown
- 2010-07-30 JP JP2012522244A patent/JP5708943B2/ja active Active
- 2010-07-30 EP EP10739973.5A patent/EP2459218B1/en active Active
- 2010-07-30 TW TW099125291A patent/TWI478716B/zh active
-
2011
- 2011-05-16 HK HK11104772.3A patent/HK1150430A1/xx unknown
-
2012
- 2012-01-26 ZA ZA2012/00661A patent/ZA201200661B/en unknown
-
2014
- 2014-01-28 US US14/166,716 patent/US9468686B2/en active Active
-
2019
- 2019-08-13 HR HRP20191465 patent/HRP20191465T1/hr unknown
- 2019-09-05 CY CY20191100931T patent/CY1122081T1/el unknown
- 2019-12-18 AR ARP190103730A patent/AR117718A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012001899B8 (pt) | soluções compreendendo polietileno glicol e eletrólitos, seu método de preparação, e recipiente e kit que as compreendem | |
UY33802A (es) | Composiciones inmunógenas que comprenden un antígeno relacionado con M72 y que tienen una fuerza iónica baja | |
EA201200153A1 (ru) | Сухая композиция для смешивания с водой (варианты), раствор для очищения кишечника на ее основе, водный раствор, набор, способ очищения толстой кишки | |
BR112013019360A2 (pt) | ingredientes, componente seco de formulação oral de baixo teor de cloreto farmaceuticamente aceitável para limpeza de cólon, solução de base de reposição de eletrólito aquosa para uso em lavagem colônica, métodos para limpar os intestinos de paciente, para preparar solução aquosa para limpeza do cólon e para aumentar substancialmente o paladar de limpador de cólon e kits para evacuação do cólon. | |
BR112015001419A2 (pt) | composto, composição farmacêutica, e, métodos para inibir romk em um paciente, para causar diurese, natriurese ou ambos e para tratamento de um ou mais distúrbios | |
IN2012DN00306A (pt) | ||
EA201490876A1 (ru) | Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей | |
BR112012032979B8 (pt) | Composição para limpeza da pele límpida, de baixa irritação, e com ph relativamente baixo e método de limpeza da pele | |
CY1114499T1 (el) | Βιοδιαθεσιμες στερεες δοσολογικες μορφες μεταξαλονης | |
BR112013033577A2 (pt) | membrana inflável para utilização em formação de imagem tridimensional | |
BR112013022653A2 (pt) | preparação para colonoscopia | |
ZA202210899B (en) | Solutons for increasing the stability and shelf life of an organ and tissue preservation solution | |
RU2020127891A (ru) | Получение соевых белковых продуктов ("s810") | |
MX364800B (es) | Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca. | |
EA201591246A1 (ru) | Раствор для сохранения сосудистых трубок | |
BR112017012978A2 (pt) | composições adjuvantes aquosas contendo eletrólitos, composições contendo substância ativa e o uso das mesmas | |
EA201190285A1 (ru) | Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия | |
JP2013500322A5 (pt) | ||
WO2012068998A3 (zh) | 一种曲安奈德眼用制剂及其制备方法 | |
WO2013173874A3 (en) | Composition and method for management of diabetes or pre-diabetes | |
RU2017142726A (ru) | Офтальмическая композиция, содержащая липоевую кислоту и мукомиметический полимер | |
BR112015005904A2 (pt) | composições contendo ácido beta-hidroxi-beta-metilbutírico e uso das mesmas | |
RU2018108842A (ru) | Способ лечения заболевания с использованием соединения, оказывающего воздействие на гликолиз | |
AR079032A1 (es) | Preparacion de un concentrado del factor h | |
RU2010142365A (ru) | Способ восстановления наружного носа при субтотальных дефектах |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/07/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |